S-8660
S-8660 is an orally active, selective inhibitor of dihydroorotate dehydrogenase (DHODH). As an antiproliferative prodrug and an analog of Brequinar (HY-108325), S-8660 exhibits immunosuppressive activity. Its effect on prolonging cardiac allograft survival is enhanced when used in combination with Cyclosporin A (HY-B0579). S-8660 can be used in studies of cardiac transplant rejection.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 96201-52-4
- 分子式: C23H16ClNO2
- 分子量:373.83
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
S-8660 selectively inhibits mitochondrial dihydroorotate dehydrogenase, disrupting de novo pyrimidine synthesis in a cell-free biochemical system[1].
S-8660 suppresses human mixed-lymphocyte responses in vitro[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:ACI (RT1a) donors; Lewis (RT11) recipients[1]
-
Dosage:5 mg/kg; 20 mg/kg
-
Administration:p.o.; once daily; starting 2 days pre-transplant for up to 30 days post-transplant
-
Result:Extended cardiac allograft survival in a dose-dependent manner.
Achieved a median graft survival time of 32 days with the tapered dose regimen, compared to control median survival of 7 days.
化学情報
-
CAS 番号 96201-52-4
-
分子量 373.83
-
分子式 C23H16ClNO2
-
SMILES
O=C(O)C1=C(C(C2=CC=C(C=C2)C3=CC=CC=C3)=NC4=CC=CC(Cl)=C14)C
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
- S-8660
- 96201-52-4
- S8660
- S 8660
- Dihydroorotate Dehydrogenase
- delayed-type hypersensitivity
- antiproliferative prodrug
- immunosuppressive activity
- cardiac allograft rejection
- dihydroorotate dehydrogenase
- cardiac allograft survival
- de novo pyrimidine synthesis
- rats
- cyclosporine
- human mixed-lymphocyte responses
- Inhibitor
- inhibitor
- inhibit